Characteristics of a Unique Visual Field Defect Attributed to Vigabatrin

Visual field defect associated with vigabatrin: observational cohort study.

1 Wilkinson RG. Income distribution and life expectancy. BMJ 1992;304:165-8. 2 Wilkinson RG. Unhealthy societies: the afflictions of inequality. London: Routledge, 1996. 3 Kaplan GA, Pamuk E, Lynch JW, Cohen RD, Balfour JL. Inequality in income and mortality in the United States: analysis of mortality and potential pathways. BMJ 1996;312:999-1003. 4 Kennedy BP, Kawachi I, Prothrow-Stith D. Inco...

Does the Swedish Interactive Threshold Algorithm (SITA) accurately map visual field loss attributed to vigabatrin?

BACKGROUND Vigabatrin (VGB) is an anti-epileptic medication which has been linked to peripheral constriction of the visual field. Documenting the natural history associated with continued VGB exposure is important when making decisions about the risk and benefits associated with the treatment. Due to its speed the Swedish Interactive Threshold Algorithm (SITA) has become the algorithm of choice...

Title:does the Swedish Interactive Threshold Algorithm (sita) Accurately Map Visual Field Loss Attributed to Vigabatrin?

Coleman of vigabatrin induced visual field defects

http://bjo.bmj.com/content/86/8/931.full.html Updated information and services can be found at: These include: References http://bjo.bmj.com/content/86/8/931.full.html#ref-list-1 This article cites 3 articles, 2 of which can be accessed free at: service Email alerting the top right corner of the online article. Receive free email alerts when new articles cite this article. Sign up in the box at...

Visual field defects associated with vigabatrin therapy.

OBJECTIVE To estimate the prevalence of visual field defects in patients taking the anticonvulsant drug vigabatrin and to characterise the features of visual dysfunction found. METHODS Thirty three unselected patients attending neurology and epilepsy clinics were identified as taking vigabatrin and asked to attend for neuro-ophthalmic evaluation. A control group of 16 patients with epilepsy u...